These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 24612987

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.
    Lontos S, Gow PJ, Vaughan RB, Angus PW.
    J Gastroenterol Hepatol; 2008 Feb; 23(2):252-5. PubMed ID: 17559367
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
    Pande C, Kumar A, Sarin SK.
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
    [Abstract] [Full Text] [Related]

  • 5. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M, Solà R, Soriano G, Andreu M, Gana J, Ortiz J, Coll S, Sàbat M, Vila MC, Guarner C, Vilardell F.
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [Abstract] [Full Text] [Related]

  • 6. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M, Kolle L, Soriano G, Ortiz J, Pamplona J, Novella MT, Villanueva C, Sainz S, Torras J, Balanzó J, Guarner C.
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Bacterial infections in liver cirrhosis].
    Papp M, Farkas A, Udvardy M, Tornai I.
    Orv Hetil; 2007 Mar 04; 148(9):387-95. PubMed ID: 17344166
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.
    Assem M, Elsabaawy M, Abdelrashed M, Elemam S, Khodeer S, Hamed W, Abdelaziz A, El-Azab G.
    Hepatol Int; 2016 Mar 04; 10(2):377-85. PubMed ID: 26660707
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.
    Bernard B, Grangé JD, Khac EN, Amiot X, Opolon P, Poynard T.
    Hepatology; 1999 Jun 04; 29(6):1655-61. PubMed ID: 10347104
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Primary prophylaxis of spontaneous bacterial peritonitis].
    Soriano G, Guarner C.
    Gastroenterol Hepatol; 1997 Jun 04; 20(6):312-4. PubMed ID: 9296848
    [No Abstract] [Full Text] [Related]

  • 15. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    Sandhu BS, Gupta R, Sharma J, Singh J, Murthy NS, Sarin SK.
    J Gastroenterol Hepatol; 2005 Apr 04; 20(4):599-605. PubMed ID: 15836710
    [Abstract] [Full Text] [Related]

  • 16. Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats.
    Guarner C, Runyon BA, Heck M, Young S, Sheikh MY.
    Dig Dis Sci; 1999 Oct 04; 44(10):1957-62. PubMed ID: 10548343
    [Abstract] [Full Text] [Related]

  • 17. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial.
    Singh N, Gayowski T, Yu VL, Wagener MM.
    Ann Intern Med; 1995 Apr 15; 122(8):595-8. PubMed ID: 7887554
    [Abstract] [Full Text] [Related]

  • 18. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
    Fernández J, Navasa M, Gómez J, Colmenero J, Vila J, Arroyo V, Rodés J.
    Hepatology; 2002 Jan 15; 35(1):140-8. PubMed ID: 11786970
    [Abstract] [Full Text] [Related]

  • 19. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J, Vila MC, Soriano G, Miñana J, Gana J, Mirelis B, Novella MT, Coll S, Sábat M, Andreu M, Prats G, Solá R, Guarner C.
    Hepatology; 1999 Apr 15; 29(4):1064-9. PubMed ID: 10094947
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.